MedImmune Cambridge

• Company Profile
• Careers @ Cambridge
• Products
• Business Development
• Drug Development
• News And Resources
  • News Archive
  • Media Contacts
  • Scientific Publications
  • Downloads
  • MedImmune Cambridge At Events
  • Image Requests
  • Web Links
• Investor Relations
• Contact

2007

2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1990-1998 |

29th October Astrazeneca Bolsters Its Worldwide Biologics Division Through Integration Of Cambridge Antibody Technology Into Medimmune

16th April Cambridge Antibody Technology And Philochem Announce Technology Evaluation Agreement

30th March Cambridge Antibody Technology Names Its New Building In Honour Of Professor Sir Aaron Klug

5th February Cambridge Antibody Technology Reports That Astrazeneca Licenses Regeneron’s Velocimmune® Technology For Discovering Human Monoclonal Antibodies

8th January Cambridge Antibody Technology Licenses Monoclonal Antibody (CAT-213) For Treatment Of Allergy Disorders To iCo Therapeutics